MXPA05008902A - Soluciones de drogas en mentol. - Google Patents
Soluciones de drogas en mentol.Info
- Publication number
- MXPA05008902A MXPA05008902A MXPA05008902A MXPA05008902A MXPA05008902A MX PA05008902 A MXPA05008902 A MX PA05008902A MX PA05008902 A MXPA05008902 A MX PA05008902A MX PA05008902 A MXPA05008902 A MX PA05008902A MX PA05008902 A MXPA05008902 A MX PA05008902A
- Authority
- MX
- Mexico
- Prior art keywords
- drugs
- menthol solutions
- menthol
- solutions
- compositions
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 title abstract 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 title abstract 2
- 229940041616 menthol Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44924603P | 2003-02-20 | 2003-02-20 | |
| PCT/US2004/004684 WO2004073686A2 (en) | 2003-02-20 | 2004-02-17 | Menthol solutions of drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05008902A true MXPA05008902A (es) | 2005-10-05 |
Family
ID=32908699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05008902A MXPA05008902A (es) | 2003-02-20 | 2004-02-17 | Soluciones de drogas en mentol. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040198646A1 (enExample) |
| EP (1) | EP1596832A2 (enExample) |
| JP (1) | JP2006524190A (enExample) |
| KR (1) | KR20050116368A (enExample) |
| CN (1) | CN1882313A (enExample) |
| AU (1) | AU2004212989A1 (enExample) |
| CA (1) | CA2516798A1 (enExample) |
| EA (1) | EA200501301A1 (enExample) |
| MX (1) | MXPA05008902A (enExample) |
| WO (1) | WO2004073686A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005034920A1 (en) | 2003-10-10 | 2005-04-21 | Lifecycle Pharma A/S | A solid dosage form comprising a fibrate |
| US9173847B2 (en) | 2003-10-10 | 2015-11-03 | Veloxis Pharmaceuticals A/S | Tablet comprising a fibrate |
| EP1680086A2 (en) * | 2003-10-10 | 2006-07-19 | LifeCycle Pharma A/S | A solid dosage form comprising a fibrate and a statin |
| WO2005094814A1 (ja) * | 2004-03-31 | 2005-10-13 | Kowa Co., Ltd. | 外用剤 |
| EP1720523A2 (en) * | 2004-08-13 | 2006-11-15 | Teva Pharmaceutical Industries Ltd | Cyclosporin formulations |
| EP1707197A1 (en) | 2005-03-30 | 2006-10-04 | Teva Pharmaceutical Industries Ltd. | Formulations containing fenofibrate and a surfactant mixture |
| US20060222707A1 (en) * | 2005-03-30 | 2006-10-05 | Lerner E I | Formulations of fenofibrate |
| MX2007011858A (es) * | 2005-03-30 | 2008-03-25 | Teva Pharma | Formulaciones mejoradas de fenofibrato que contienen mentol o peg/poloxamero. |
| AU2006264407B2 (en) * | 2005-07-04 | 2012-08-30 | Ramu Krishnan | Improved drug or pharmaceutical compounds and a preparation thereof |
| US20070015833A1 (en) * | 2005-07-18 | 2007-01-18 | Moshe Flashner-Barak | Formulations of fenofibrate containing menthol |
| US20070015834A1 (en) * | 2005-07-18 | 2007-01-18 | Moshe Flashner-Barak | Formulations of fenofibrate containing PEG/Poloxamer |
| JP2022548221A (ja) * | 2019-09-09 | 2022-11-17 | テジュン ファーマシューティカル カンパニー リミテッド | シクロスポリンおよびメントール含有ナノエマルジョン点眼組成物およびその製造方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6331318B1 (en) * | 1994-09-30 | 2001-12-18 | Emisphere Technologies Inc. | Carbon-substituted diketopiperazine delivery systems |
| US5567592A (en) * | 1994-02-02 | 1996-10-22 | Regents Of The University Of California | Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal |
| US5665386A (en) * | 1995-06-07 | 1997-09-09 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
| CA2224227A1 (en) * | 1995-06-07 | 1996-12-19 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
| US5716928A (en) * | 1995-06-07 | 1998-02-10 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
| US5968972A (en) * | 1995-10-26 | 1999-10-19 | Baker Norton Pharmaceuticals, Inc. | Method for increasing the oral bioactivity of pharmaceutical agents |
| AU2190697A (en) * | 1996-04-12 | 1997-11-07 | Flemington Pharmaceutical Corporation | Buccal polar spray or capsule |
| US20010049363A1 (en) * | 1998-05-08 | 2001-12-06 | Warner-Lambert Company | Oral composition containing NSAIDs and essential oils |
| US6878693B2 (en) * | 2001-09-28 | 2005-04-12 | Solubest Ltd. | Hydrophilic complexes of lipophilic materials and an apparatus and method for their production |
| DE60330322D1 (de) * | 2002-03-26 | 2010-01-14 | Teva Pharma | Arzneimittel-mikroteilchen |
-
2004
- 2004-02-17 WO PCT/US2004/004684 patent/WO2004073686A2/en not_active Ceased
- 2004-02-17 EP EP04711866A patent/EP1596832A2/en not_active Withdrawn
- 2004-02-17 CN CNA2004800101740A patent/CN1882313A/zh active Pending
- 2004-02-17 JP JP2006501172A patent/JP2006524190A/ja active Pending
- 2004-02-17 CA CA002516798A patent/CA2516798A1/en not_active Abandoned
- 2004-02-17 AU AU2004212989A patent/AU2004212989A1/en not_active Abandoned
- 2004-02-17 EA EA200501301A patent/EA200501301A1/ru unknown
- 2004-02-17 MX MXPA05008902A patent/MXPA05008902A/es unknown
- 2004-02-17 US US10/781,543 patent/US20040198646A1/en not_active Abandoned
- 2004-02-17 KR KR1020057015441A patent/KR20050116368A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004073686A2 (en) | 2004-09-02 |
| EP1596832A2 (en) | 2005-11-23 |
| US20040198646A1 (en) | 2004-10-07 |
| AU2004212989A1 (en) | 2004-09-02 |
| WO2004073686A3 (en) | 2004-11-04 |
| JP2006524190A (ja) | 2006-10-26 |
| KR20050116368A (ko) | 2005-12-12 |
| CA2516798A1 (en) | 2004-09-02 |
| CN1882313A (zh) | 2006-12-20 |
| EA200501301A1 (ru) | 2006-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200716646A (en) | (S)-N-methylnaltrexone | |
| TNSN05254A1 (en) | Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics | |
| TW200510416A (en) | P38 inhibitors and methods of use thereof | |
| TW200637522A (en) | Skin treatment articles and methods | |
| UA86591C2 (ru) | Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе | |
| CA2672094C (en) | Methods and apparatus for identifying subject matter in view data | |
| MY146112A (en) | Long-term feed - cancer patient | |
| PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
| IL169897A0 (en) | Sustituted heterocycles | |
| MX2010005589A (es) | Composicion para el cuidado personal. | |
| TW200501965A (en) | Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle | |
| TW200508197A (en) | Indolone-acetamide derivatives, processes for preparing them and their uses | |
| MXPA05008902A (es) | Soluciones de drogas en mentol. | |
| IL186707A (en) | Mitotic quinine inhibitors and medical preparations containing them | |
| IL171974A0 (en) | Tetrahydrocarbazole derivatives and their pharmaceutical use | |
| TW200602076A (en) | O, O'-amidomalonate and N, O-amidomalonate platinum complexes | |
| MY149864A (en) | Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties | |
| NO20076120L (no) | Stabile nanopartikkelformuleringer | |
| TW200630343A (en) | 2-Alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof | |
| SE0300457D0 (sv) | Novel compounds | |
| MXPA05009428A (es) | Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas. | |
| TW200640858A (en) | Substituted pyrroles, compositions containing them, method of manufacture and use | |
| ATE435647T1 (de) | Rutheniumkomplexe zur krebsbehandlung | |
| WO2006020984A3 (en) | Cyclosporin formulations | |
| MX2007000399A (es) | Forma de dosis estable para derivados de fenilalanina. |